Ariane van der Straten
Senior Fellow, Director, Women’s Global Health Imperative
Ariane van der Straten, PhD, is an expert in female-initiated HIV-prevention methods. Her research focuses on acceptability and adherence to new biomedical HIV-prevention methods and multipurpose technologies for contraception and HIV prevention.
She has led or participated in the development and implementation of major research projects in Africa and the U.S., including clinical trials of diaphragm and gel, oral, and vagina Tenofovir-based pre-exposure prophylaxis and vaginal rings. Dr. van der Straten has also led several studies focusing on adherence-related issues in the context of prevention trials.
Currently, she is working on a large multidisciplinary project to develop and test the use of a long-lasting, injectable, biodegradable, HIV-prevention device.
In addition, Dr. van der Straten serves as an associate professor at the University of California, San Francisco.
MPH, Public Health, The Johns Hopkins University, School of Hygiene and Public Health; PhD, Zoology (summa cum laude), University of Brussels, Laboratory of Genetics; BS (summa cum laude), Zoology-Molecular Biology, University of Louvain, Belgium.
- Female-Initiated HIV Prevention Methods: Microbicides, Barrier Methods, and PrEP
- Acceptability, Adherence, and Their Measurement
- Clinical Trials
- Qualitative and Quantitative Research Methods
- February 7, 2015
HIV prevention trial, managed from Pittsburgh, fails after subjects lie
– Pittsburgh Post-Gazette
- November 13, 2014
Yes, doctor, I took my anti-HIV meds (but really, I didn't)
- October 29, 2014
Women who took part in VOICE speak up about why they didn't use HIV prevention products
– Science Codex